Clinical Trial

Swiss Revision Cohort

Study acronym: REVCO
Recruiting
View on ClinicalTrials.gov →
Summary
This study follows patients with infections after a joint replacement over time. During follow-up, treatment outcomes are carefully measured to determine whether the infection can be cured. In addition, factors that may change infection cure rates are examined, including the patient's overall health, the type of bacteria causing the infection, and the surgical and antibiotic treatments used. The goal is to understand what leads to more frequent cure and to improve future care.
Trial Details
NCT Number NCT07473089
Lead Sponsor Insel Gruppe AG, University Hospital Bern
Conditions Joint (Knee or Hip Replacement), Infection as Complication of Medical Care
Enrollment 329 participants
Start Date 2022-09-23
Primary Completion 2030-01 (estimated)
Study Completion 2030-01 (estimated)
Updated on ClinicalTrials.gov 2026-03-16